Open AccessThe diagnostic yield of fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in recurrent testicular seminoma
Author(s) -
Athanasios Bantis,
Petros Sountoulides,
Linda Metaxa,
Pavlos Pavlidis,
E. Aggelonidou,
Halil Arif,
Athanasios Zisimopoulos
Publication year - 2016
Publication title -
urology annals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.355
H-Index - 20
eISSN - 0974-7834
pISSN - 0974-7796
DOI - 10.4103/0974-7796.192090
Subject(s) - seminoma , medicine , positron emission tomography , positron emission tomography computed tomography , computed tomography , fluorodeoxyglucose , radiology , positron emission , nuclear medicine , tomography , chemotherapy
The use of positron emission tomography-computed tomography (PET-CT) scan imaging is undoubtedly a significant evolution in oncological urology, although at present of limited use in every day urology practice. The aim of this study is to highlight the indication and diagnostic accuracy of fluorine-18 fluorodeoxyglucose PET/CT in the staging of a patient with metachronous bilateral testicular seminoma, elevated tumor markers, and equivocal conventional imaging findings.